#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pemphigus Acute lymphocytic leukaemia recurrent Krabbe's disease Pulmonary fibrosis Drug eruption Thalassaemia alpha Idiopathic pulmonary fibrosis Endocrine ophthalmopathy Idiopathic intracranial hypertension Malignant glioma Astrocytoma malignant Polycythaemia vera Chronic hepatitis B Kaposi's sarcoma Anti-glomerular basement membrane disease More trials…

    Learn about Rare Diseases

    Alexander disease – Trials in Disease Adrenocortical carcinoma – Life with Disease Sarcoidosis – Life with Disease Angiosarcoma – Diagnostics Thrombotic thrombocytopenic purpura Urea cycle disorder Hairy cell leukaemia – Basic Information Antisynthetase syndrome – Trials in Disease Malignant fibrous histiocytoma – Life with Disease Hypereosinophilic syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Istem-01 Lolium Perenne Pollen Extract Aceclofenac Taminadenant Lonapegsomatropin Fasudil Hydrochloride Antiemetics And Antinauseants Asfotase Alfa Quemliclustat Zasocitinib AGA2118 Imipenem Chlorpromazine Morf-057 Tabelecleucel TIFCEMALIMAB Iph6501 Omp65 Nirogacestat Hydrobromide Efmoroctocog Alfa More therapies…

    Learn about Your Condition

    Lymphoma Mast cell activation syndrome Hepatic encephalopathy Soft tissue sarcoma Infectious pleural effusion Muscle injury Neuromyopathy Ocular myasthenia T-cell type acute leukaemia Dyskinesia Desmoplastic melanoma Pancreaticoduodenectomy Alexander disease Anaemia of chronic disease Peritoneal abscess More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Study on Heparin Sodium and Sodium Chloride for Patients with Lymphoma or Myeloma Undergoing Stem Cell Collection

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Lymphoma
    • Plasma cell myeloma
    Investigated Drugs:
    • Heparin Sodium
    • Sodium Chloride
    Sweden

  • Study on the Safety and Effectiveness of AZD0486 and Tocilizumab for Adolescents and Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
    • Tocilizumab
    France Germany Italy Spain

  • Study on the Effectiveness and Safety of Odronextamab Compared to Standard Treatment in Adults with Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Gemcitabine
    • Ifosfamide
    • Odronextamab
    Austria Belgium Czechia Germany Hungary Italy +4

  • Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Chlorhexidine Dihydrochloride
    • Imetelstat Sodium
    • Diphenhydramine Hydrochloride
    France Germany

  • Study on Joint Health in Hemophilia A and B Patients Using Efmoroctocog Alfa or Eftrenonacog Alfa

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Factor IX deficiency
    • Factor VIII deficiency
    Investigated Drugs:
    • Efmoroctocog Alfa
    • Eftrenonacog Alfa
    Bulgaria Croatia Czechia France Hungary Ireland +4

  • Study Comparing R-MINI-CHOP and R-MINI-CHP with Polatuzumab Vedotin for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older or Frail Patients Aged 75 and Older

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    Denmark Estonia Finland Italy Norway Sweden
Previous Page
1 … 43 44 45 46 47 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!